levamisole has been researched along with Carcinoma, Renal Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksoy, H; Baltaci, S; Bedük, Y; Seçkiner, I; Türkölmez, K | 1 |
| Efferth, T; Volm, M | 1 |
| A'Hern, R; Ahmed, FY; Atkinson, H; Gore, ME; Leonard, GA; Lorentzos, A; Moore, J; Nicolson, MC; Riches, PG; Taylor, AE | 1 |
| Creagan, ET; Hestorff, RD; Krook, JE; Kugler, JW; Mailliard, JA; Marschke, RF; Michalak, JC; Nair, S; Suman, VJ; Tschetter, LK | 1 |
| Buzogány, I; Döbrönte, R; Fazekas, A; Kaiser, L; Magyarlaki, T; Nagy, J; Simon, B; Sükösd, F | 1 |
| Böttger, I; Hofmann, R; Lehmer, A; Reidel, G; Schütz, W | 1 |
2 trial(s) available for levamisole and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma.
Topics: Adjuvants, Immunologic; Adult; Carcinoma, Renal Cell; Humans; Interleukin-2; Kidney Neoplasms; Leukocyte Count; Levamisole; Lymphocytes; Melanoma | 1996 |
Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Therapy, Combination; Female; Humans; Interleukin-2; Kidney Neoplasms; Levamisole; Male; Middle Aged; Recombinant Proteins; Survival Analysis | 1998 |
4 other study(ies) available for levamisole and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Renal Cell; Drug Therapy, Combination; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Levamisole; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Treatment Outcome | 2001 |
Increase of alkaline phosphatase in multidrug-resistant tumor cells and their cross-resistance to 6-thioguanine.
Topics: Alkaline Phosphatase; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Division; Doxorubicin; Drug Resistance; Humans; Immunohistochemistry; Levamisole; Mice; Radioimmunoassay; Sarcoma 180; Thioguanine; Tumor Cells, Cultured; Vincristine | 1993 |
Prognostic histological and immune markers of renal cell carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma, Renal Cell; Combined Modality Therapy; Disease Progression; Follow-Up Studies; Humans; Immunoenzyme Techniques; Immunologic Factors; Immunotherapy; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Levamisole; Lymphocytes, Tumor-Infiltrating; Neoplasm Proteins; Neoplasm Staging; Nephrectomy; Prognosis; Recombinant Proteins; Treatment Outcome; Vinblastine | 2001 |
Natural killer cells in patients with renal cell cancer.
Topics: Bacterial Outer Membrane Proteins; Carcinoma, Renal Cell; Cell Line; Humans; Interferons; Kidney Neoplasms; Killer Cells, Natural; Levamisole | 1985 |